EUVIMEDEUVIMED entdecken
Crossref

Assessing Oral Glucose Tolerance Test in Children with Cystic Fibrosis

Hanife Ayşegül Arsoy, Özlem Kara

Harran Üniversitesi Tıp Fakültesi Dergisi · 26.06.2026 · 23 (2) · 313-321

DOI: 10.35440/hutfd.1924389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Harran Üniversitesi Tıp Fakültesi Dergisi, online erschienen am 26.06.2026. Verfasst von Hanife Ayşegül Arsoy und 1 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this study is to determine the presence and frequency of cystic fibrosis- related diabetes (CFRD) and abnormal glucose tolerance (AGT) in children with cystic fibrosis (CF) across various age groups using an oral glucose tolerance test (OGTT), and to evaluate their association with nutritional status.Materials and Methods: Twenty-five patients diagnosed with CF underwent a standard 2-hour OGTT while in a clinically stable period. Plasma glucose and insulin levels were measured. Patients were categorised as normal glucose tolerance (NGT), indeterminate glucose tolerance (INDET), impaired glucose tolerance (IGT), CFRD or impaired fasting glucose (IFG). All classifications other than NGT were categorized as AGT. Clinical and anthropometric data was recorded, and all statistical analyses performed using SPSS 23.

Results

In the present study, 60% of the subjects were female. The mean chronological age at which the OGTT was performed was 9.44 ± 5.36 years (min 1.2 years). None of the patients had fasting hyperglycaemia. NGT was detected in 12 patients (48%), and AGT in 13 patients (52%). Of the 25 CF patients, 5 (20%) were diagnosed with CFRD, 2 (8%) of whom were less than 10 years old at the time of their diagnosis. The patients with AGT had a lower mean body weight standard deviation (SD) and body mass index SD than those with NGT.

Conclusions

The findings of this study suggest that the possibility of CFRD and AGT should be considered in the context of CF, and that screening with an OGTT may be necessary starting at age five. Weight loss and failure to gain weight may be early signs of CFRD and AGT.

Zitieren

APA

Arsoy, H. A., & Kara, Ö. (2026). Assessing Oral Glucose Tolerance Test in Children with Cystic Fibrosis. Harran Üniversitesi Tıp Fakültesi Dergisi, 23(2), 313-321. https://doi.org/10.35440/hutfd.1924389

Vancouver

Arsoy HA, Kara Ö. Assessing Oral Glucose Tolerance Test in Children with Cystic Fibrosis. Harran Üniversitesi Tıp Fakültesi Dergisi. 2026;23(2):313-321. doi:10.35440/hutfd.1924389

BibTeX
@article{Arsoy2026,
  author = {Arsoy, Hanife Ayşegül and Kara, Özlem},
  title = {Assessing Oral Glucose Tolerance Test in Children with Cystic Fibrosis},
  journal = {Harran Üniversitesi Tıp Fakültesi Dergisi},
  year = {2026},
  volume = {23},
  number = {2},
  pages = {313--321},
  doi = {10.35440/hutfd.1924389}
}
Kostenlos starten →